A low-cost, early stage colon cancer blood test developed by a Knoxville-based company is a step closer to hitting the market in hopes of saving thousands of lives.
EDP Biotech developed ColoMarker. The test has a 95-percent accuracy rate in detecting early stage colon cancer in the blood.
EDP Biotech vice president of business development, Eric Mayer, and vice president of research and development, Tommye Jordan, joined us in the 10News studio with more information. You can watch that entire conversation in the video above.